Literature DB >> 9457188

Pancreatic cancer: value of dual-phase helical CT in assessing resectability.

S J Diehl1, K J Lehmann, M Sadick, R Lachmann, M Georgi.   

Abstract

PURPOSE: To evaluate the use of dual-phase helical computed tomography (CT) (with or without CT angiography) to assess resectability in patients suspected to have pancreatic cancer.
MATERIALS AND METHODS: Tumor resectability was prospectively evaluated in 89 patients who later underwent surgery for suspected pancreatic cancer. Helical CT scans were obtained in the vascular phase and a phase of maximal hepatic enhancement. CT angiograms were produced with multiprojection volume reconstruction and maximum-intensity projection. CT results were correlated with surgical and histopathologic results.
RESULTS: Helical CT allowed detection of pancreatic cancer in 74 of 76 cases (97%). There were six false-positive results (positive predictive value, 92%). For prediction of irresectability, helical CT had an accuracy of 91%, negative predictive value of 79%, and sensitivity of 91%. Helical CT allowed detection of liver metastases in 21 of 28 cases (75%), nodal involvement in 13 of 24 cases (54%), and vascular invasion in 35 of 40 cases (88%). CT angiography demonstrated 30 of the 35 cases of vascular invasion detected with helical CT (86%).
CONCLUSION: Use of dual-phase helical CT improves prediction of resectability in patients with pancreatic cancer. CT angiography cannot show all of the findings seen on helical scans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457188     DOI: 10.1148/radiology.206.2.9457188

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  48 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

Review 2.  Multidetector CT and three-dimensional imaging of the pancreas: state of the art.

Authors:  Karen M Horton
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 3.  The role of transabdominal ultrasonography, helical computed tomography, and magnetic resonance cholangiopancreatography in diagnosis and management of pancreatic disease.

Authors:  I D Norton; J E Clain
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 4.  Magnetic resonance imaging of pancreatic adenocarcinoma.

Authors:  L M Fayad; D G Mitchell
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 5.  Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas.

Authors:  Masayuki Kitano
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

6.  Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectability.

Authors:  Vyacheslav I Egorov; Roman V Petrov; Elena N Solodinina; Gregory G Karmazanovsky; Natalia S Starostina; Natalia A Kuruschkina
Journal:  World J Gastrointest Surg       Date:  2013-04-27

Review 7.  Endoscopic ultrasonography in the diagnosis and staging of pancreatic neoplasms.

Authors:  P Protiva; A V Sahai; B Agarwal
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 8.  Advanced 3-D imaging for the evaluation of pancreatic cancer with multidetector CT.

Authors:  E Tamm; C Charnsangavej; J Szklaruk
Journal:  Int J Gastrointest Cancer       Date:  2001

9.  Assessment of vascular invasion in pancreatic head cancer with multislice spiral CT: value of multiplanar reconstructions.

Authors:  Melanie Brügel; Thomas M Link; Ernst J Rummeny; Peter Lange; Jörg Theisen; Martin Dobritz
Journal:  Eur Radiol       Date:  2004-04-09       Impact factor: 5.315

10.  Pancreatic adenocarcinoma: analysis of the effect of various concentrations of contrast material.

Authors:  Yoshihiko Fukukura; Hiroyuki Hamada; Takuro Kamiyama; Tomohide Yoneyama; Koji Takumi; Masayuki Nakajo
Journal:  Radiat Med       Date:  2008-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.